Skip to main navigation Skip to search Skip to main content

First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation

Research output: Contribution to journalArticlepeer-review

Abstract

Donor cell leukemia is a rare complication after allogeneic hematopoietic stem cell transplantation. A 12-month-old boy underwent unrelated donor umbilical cord blood transplant (UCBT) for refractory Langerhan's cell histiocytosis. Forty months after transplantation, he developed acute myeloid leukemia. Cytogenetic and molecular analysis confirmed donor cell origin. The Cord Blood Bank (CBB) contacted the donor's family and established that the child, now 7 years old, was healthy. This represents the first reported case of donor cell leukemia following UCBT. This case illustrates that donor cell leukemia is a rare but real event after UCBT as with other stem cell sources and highlights the need for CBBs to maintain linkage data between donors and recipients.

Original languageEnglish (US)
Pages (from-to)4377-4380
Number of pages4
JournalBlood
Volume106
Issue number13
DOIs
StatePublished - Dec 15 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation'. Together they form a unique fingerprint.

Cite this